Skip to main
STAA

STAAR Surgical (STAA) Stock Forecast & Price Target

STAAR Surgical (STAA) Analyst Ratings

Based on 8 analyst ratings
Buy
Strong Buy 25%
Buy 13%
Hold 63%
Sell 0%
Strong Sell 0%

Bulls say

Staar Surgical is expected to continue its positive momentum as its strong sales performance and improved financials demonstrate resilient demand for its market-leading ICL products. Improved EBITDA, lower expenses, and expanding global presence, particularly in the Chinese market, will continue to drive growth and value creation for the company. Increased production capacity and disciplined cost management will also improve cash flow for the company in the future.

Bears say

Staar Surgical is showing signs of a potential turnaround, with improved financial performance and a strong outlook for China, a key market for the company. Despite challenges such as competition and regulatory hurdles, the company's strong market position in phakic IOLs and innovative technology may continue to drive growth in the long-term. However, risks such as macroeconomic conditions and dependence on distributors should not be overlooked.

STAAR Surgical (STAA) has been analyzed by 8 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 13% recommend Buy, 63% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of STAAR Surgical and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About STAAR Surgical (STAA) Forecast

Analysts have given STAAR Surgical (STAA) a Buy based on their latest research and market trends.

According to 8 analysts, STAAR Surgical (STAA) has a Buy consensus rating as of Jun 3, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $29.69, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $29.69, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

STAAR Surgical (STAA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.